Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
15 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Enfortumab“
Suchtreffer
Begriffe & Kennungen
Padcev · 4.8 · In clinical studies of enfortumab vedotin as monotherapy, hyperglycaemia (blood glucose >13.9 mmol/L) occurred
Eintrag öffnenPadcev · 4.8 · In clinical studies of enfortumab vedotin as monotherapy, peripheral neuropathy occurred in 53% (422) of the 7
Eintrag öffnenPadcev · 4.8 · In clinical studies of enfortumab vedotin as monotherapy, pneumonitis/ILD occurred in 3.3% (26) of the 793 pat
Eintrag öffnenPadcev · 4.8 · In clinical studies of enfortumab vedotin as monotherapy, skin reactions occurred in 57% (452) of the 793 pati
Eintrag öffnenPadcev · 4.8 · In clinical studies of enfortumab vedotin in combination with pembrolizumab, pneumonitis/ILD occurred in 8.8%
Eintrag öffnenPadcev · 4.8 · In clinical studies of enfortumab vedotin in combination with pembrolizumab, skin reactions occurred in 67% (7
Eintrag öffnenPadcev · 4.8 · Table 5. Adverse reactions in patients treated with enfortumab vedotin
Eintrag öffnenPadcev · 4.8 · The incidence of treatment-emergent anti-enfortumab vedotin antibody formation was consistent when assessed fo
Eintrag öffnenPadcev · 4.8 · The most common adverse reactions with enfortumab vedotin in combination with pembrolizumab were pruritus (44.
Eintrag öffnenPadcev · 4.8 · The most common adverse reactions with enfortumab vedotin were alopecia (47.7%), decreased appetite (47.2%), f
Eintrag öffnenPadcev · 4.8 · The safety of enfortumab vedotin was evaluated as monotherapy in 793 patients who received at least one dose o
Eintrag öffnenPadcev · 4.8 · The safety of enfortumab vedotin was evaluated in combination with pembrolizumab in 1 134 patients who receive
Eintrag öffnenPadcev · 4.8 · When enfortumab vedotin is administered in combination with pembrolizumab, refer to the SmPC for pembrolizumab
Eintrag öffnenenfortumab
Eintrag öffnenenfortumab vedotin
Eintrag öffnen